Dramatically accelerate research on infectious diseases and immune system diseases by providing special blood cell-like cells for research.
Our MPV and MYLC cells, produced with regenerative medicine technologies, will solve the shortage of experimental cells for researches on malaria and other infectious diseases, and help researchers accelerate their experiments exponentially.